|
Dusica Babovic-Vuksanovic, M.D.
![]() Dusica Babovic-Vuksanovic, M.D.
Location:
Minnesota
SummaryClinical Studies and Translational Research in the Area of Neurofibromatosis
Examples of Research Projects Completed Protocols: PI: A pilot, phase II, open-label clinical trial of pirfenidone (an antifibrotic agent) in adult patients with Neurofibromatosis type I and plexiform and paraspinal neurofibromas (PI). The study was coordinated through Mayo Cancer Center. Co-PI: "Phase I Clinical trial of Pirfenidone in Childen and Adolescents with plexifom neurofibromas." Study was a part of multi-center clinical trial, coordinated by NCI. Current Protocols: Co-PI: "Phase II Clinical Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibtromatosis Type I and Progressive Plexiform Neurofibromas," coordinated by NCI, in collaboration with Childrens National Medical Center (PI Dr. Roger Packer). Protocols in Development: PI: "A Phase-2 Study of AZD2171 in Adult Patients with Neurofibromatosis Type I and Extensive Plexiform and Paraspinal Neurofibromas," coordinated by Cancer Therapy Evaluation Program (CTEP) and sponsored by AstraZeneca Pharmaceuticals; multicenter protocol with Mayo Clinic lead. My research also involves several collaborative basic research studies in the field of neurofibromatosis, in conjuntion with Mayo Neuro-Oncology program, Mayo Radiology Department, and Mayo Neurosurgery Department. My research interests include overgrowth syndromes, as well as various genetic syndromes and metabolic disorders. Recent publicationsEducation
Clinician Investigator Fellow
Fellowship
Residency
Visiting Clinician
MMedSc
–
Basic Research.
Thesis: "Diagnostic and prognostic value of limited joint mobility and skin changes in juvenile diabetics"
Residency
Research Fellowship
M.D.
|
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.